$LSTA

$1.06 +$0.06 (6.44%) Close

$LSTA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$LSTA Management Team

Mr. John Menditto

Vice President - Investor Relations & Corporate Communications

Age -

Compensation -

Sex Male

Dr. Gregory Brown

Independent Chairman of the Board

Age 72

Compensation $154.5K USD

Sex Male

Dr. David Mazzo

President

Chief Executive Officer

Director

Age 68

Compensation $1.691M USD

Sex Male

Dr. Kristen Buck

Executive Vice President - Research & Development

Chief Medical Officer

Age 51

Compensation $1.065M USD

Sex Female

Mr. James Nisco

Senior Vice President - Finance and Treasury

Chief Accounting Officer

Age 54

Compensation $516.2K USD

Sex Male

Mr. Tariq Imam

Senior Vice President

Business Development and Operations and General Counsel

Age 42

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. John Menditto Vice President - Investor Relations & Corporate Communications	-	-	Male
Dr. Gregory Brown Independent Chairman of the Board	72	$154.5K USD	Male
Dr. David Mazzo President Chief Executive Officer Director	68	$1.691M USD	Male
Dr. Kristen Buck Executive Vice President - Research & Development Chief Medical Officer	51	$1.065M USD	Female
Mr. James Nisco Senior Vice President - Finance and Treasury Chief Accounting Officer	54	$516.2K USD	Male
Mr. Tariq Imam Senior Vice President Business Development and Operations and General Counsel	42	-	Male

Board of Directors

From the proxy statement filed Oct 19, 2026

Directors

serving now

Independent

5 of 5

stated in the proxy; 3 not stated

Average tenure

6.1 years

from year joined

CEO also chairs the board

Gregory B. Brown, M.D.

Director	Age	On board	Independent	Committees	Other public boards	Pay
Cynthia L. Flowers	66	2018 8 years	Independent	None stated	Hikma Pharmaceuticals PLC	Not stated
Ted W. Love	67	2026 0 years	Independent	None stated	Jazz Pharmaceutics plc, Gilead Sciences, Inc., Royalty Pharma plc, Structure Therapeutics Inc.	Not stated
Gregory B. Brown, M.D. Board chair	72	2016 10 years	Independent	None stated	Aquestive Therapeutics	Not stated
Heidi Henson	60	2022 4 years	Independent	None stated	PepGen Inc., Perspective Therapeutics , Inc.	Not stated
David J. Mazzo, Ph.D. CEO	69	2015 11 years	Not stated	None stated	None stated	Paid as CEO
Mohammad Azab, M.D., M.B.A.	70	2022 4 years	Not stated	None stated	DURECT Corporation	Not stated
Steven M. Klosk, J.D.	69	2014 12 years	Not stated	None stated	None stated	Not stated
Jeffrey Farrow	65	2026 0 years	Independent	None stated	Clover Biopharmaceuticals, Ltd., Achieve Life Sciences, Inc.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Oct 19, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$LSTA Management Team

Mr. John Menditto

Dr. Gregory Brown

Dr. David Mazzo

Dr. Kristen Buck

Mr. James Nisco

Mr. Tariq Imam

Board of Directors

Related-party transactions

No related-party transactions disclosed